2252395-44-9 | J22352 |
2252403-56-6 | AMG 510 |
2252403-76-0 | 2,5,6-trichloro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide |
2252403-81-7 | 2,6-dichloro-5-fluoro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide |
2252403-82-8 | 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2252403-83-9 | Pyrido[2,3-d]pyrimidin-2(1H)-one, 4,7-dichloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]- |
2252403-84-0 | tert-butyl (S)-4-(7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate |
2252403-85-1 | 4-[(S)-4-Boc-2-methyl-1-piperazinyl]-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)pyrido[2,3-d]pyrimidin-2(1H)-one |
2252415-10-2 | Potassium Trifluoro(2-fluoro-6-hydroxyphenyl)borate |
2252416-90-1 | 1,3,5-Triazine, 2-phenyl-4,6-bis[3-(triphenylsilyl)phenyl]- |
2252417-17-5 | Hexanamide, N-[(1S)-1-(aminocarbonyl)propyl]-3-(hydroxymethyl)-, (3R)- |
2252422-32-3 | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester |
2252434-76-5 | rel-((2R,6S)-6-methylmorpholin-2-yl)methanol |
2252434-77-6 | rel-((2R,6S)-6-methylmorpholin-2-yl)methanol hydrochloride |
2252446-68-5 | 1-cyclopropyl-6,8-dimethoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo [3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic |
2252446-69-6 | 1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2252446-70-9 | 1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-71-0 | 1-cyclopropyl-6-fluoro-8-hydroxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide |
2252452-67-6 | 3-Methoxy-5H-benzofuro[3,2-c]carbazole |
2252488-69-8 | LJ570 |
2252493-06-2 | DBCO-SH |
2252518-85-5 | Feladilimab |
2253105-08-5 | tert-butyl ((3S,4R)-3-methoxypiperidin-4-yl)carbamate hemioxalate |
2253105-16-5 | methyl (3R,4R)-4-methylpiperidine-3-carboxylate |
2253105-33-6 | tert-butyl ((3S,4S)-3-methoxypiperidin-4-yl)carbamate hemioxalate |
2253105-50-7 | 3-Azetidinecarbonitrile, 1-(diphenylmethyl)-2-methyl-, (2S,3R)- |
2253105-53-0 | tert-butyl (3R,4R)-3-amino-4-methoxypiperidine-1-carboxylate |
2253105-54-1 | 1-Piperidinecarboxylic acid, 4-amino-2-(hydroxymethyl)-, 1,1-dimethylethyl ester |
2253108-14-2 | 1-methyl-1,7-diazaspiro[3.5]nonane dihydrochloride |
2253108-15-3 | 2,5-Diaza-bicyclo[4.1.0]heptane dihydrochloride |
2253108-16-4 | methyl 7-bromo-4-fluoro-2,3-dihydrobenzofuran-5-carboxylate |
2253112-90-0 | Phenol, 2-[[(3R)-3,4-dihydro-7-methoxy-6-methyl-2H-1-benzopyran-3-yl]methyl]-5-methoxy- |
2253121-62-7 | N2,N4,N6-tris(2-aminoethyl)-1,3,5-triazine-2,4,6-triamine(1:3TFA) |
2253123-16-7 | Pimicotinib |
2253165-17-0 | Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5,5-triphenyl-, (4S,4'S)- |
2253175-64-1 | CRS400393 |
2253194-12-4 | vildagliptin Impurity O |
2253194-13-5 | Vildagliptin Related Compound H |
2253629-27-3 | 9,10-[1,2]benzenoanthracene-2,3,6,7,14,15(9H,10H)-hexaone |
2253631-32-0 | 2-Oxabicyclo[2.1.1]hexane-4-carboxylic acid, 1-(fluoromethyl)- |
2253632-08-3 | 3-Azetidinemethanol, 3-methoxy-, hydrochloride (1:1) |
2253638-76-3 | 3,3-difluoro-4,4-dimethylpyrrolidine hydrochloride |
2253640-49-0 | PKC-theta inhibitor hcl |
2253640-59-2 | 3-Pyridinemethanamine, 2,6-difluoro-, hydrochloride (1:1) |
2253650-62-1 | (S)-2-(1,8-Naphthyridin-2-yl)-4-phenyl-4,5-dihydrooxazole |
2253663-81-7 | 3,9-bis(2-methylene-((3-(1,1-dicyanomethylene)-6,7-dichloro)-indanone))-5,5,11,11-tetrakis(4-hexylphenyl)-dithieno[2,3-d:2',3'-d']-s-indaceno[1,2-b:5,6-b']dithiophene |
2253707-77-4 | RoxithroMycin-d7 |
2253710-45-9 | Cyanine7 DBCO |
2253733-10-5 | HADA |
2253733-11-6 | NADA-green |
2253733-37-6 | GLUT4 activator 1 |
2253743-32-5 | 1-Azabicyclo[2.2.2]octane-4-methanol, α-[1,1'-biphenyl]-2-yl-α-phenyl- |
2253743-40-5 | 1-Azoniabicyclo[2.2.2]octane, 4-([1,1'-biphenyl]-4-ylhydroxyphenylmethyl)-1-[2-(phenylmethoxy)ethyl]-, bromide (1:1) |
2253744-53-3 | DJ-V159 |
2253744-54-4 | 1,3,4-Oxadiazole, 2-[[(2,6-dichlorophenyl)methyl]thio]-5-(1H-pyrrol-2-yl)- |
2253744-56-6 | 1H-Purine-2,6-dione, 7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-3,7-dihydro-1,3-dimethyl-8-(1-piperazinyl)- |
2253748-36-4 | 1H-?Thioxantheno[2,?1,?9-?def]?isoquinoline-?1,?3(2H)?-?dione, 5-?bromo-?2-?(1-?ethylpropyl)?- |
2253771-11-6 | Empagliflozin Impurity |
2253772-47-1 | 3,4-DIHYDRO-2H-PYRIDO[4,3-B][1,4]OXAZINE |
2253791-37-4 | cis-2-Methoxy-cyclobutylamine hydrochloride |
2253791-96-5 | INDEX NAME NOT YET ASSIGNED |
2253870-61-8 | INDEX NAME NOT YET ASSIGNED |
2253871-63-3 | (2-Ethoxy-4-formylphenyl)boronic acid |
2253878-09-8 | BCL6-IN-5 |
2253878-44-1 | BCL6-IN-3 |
2253879-65-9 | 2H-Benzimidazol-2-one, 5-[[5-chloro-2-(2,2,6,6-tetramethyl-4-morpholinyl)-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- |
2253880-32-7 | 2H-Benzimidazol-2-one, 5-amino-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- |
2253945-67-2 | 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyethyl)amino]-2,4,6-triiodo- |
2253947-15-6 | INDEX NAME NOT YET ASSIGNED |
2253947-17-8 | INDEX NAME NOT YET ASSIGNED |
2253947-47-4 | Urea, N-[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxo-3-pyrrolidinyl]-N'-phenyl- |
2253951-38-9 | 1,3-Propanediol, 2-amino-2-[[4-[2-[3-[[2-[(1S)-1-hydroxyethyl]-1H-imidazol-1-yl]methyl]-5-isoxazolyl]ethynyl]phenoxy]methyl]- |
2253964-85-9 | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione |
2253964-98-4 | N-Depiperidin-3-amine Linagliptin Dimer |
2253965-01-2 | Boc-aminooxy-amide-PEG4-propargyl |
2253965-03-4 | Aminooxy-amido-PEG4-propargyl |
2253969-12-7 | 4,5-b']dithiophene-3,9-diamine |
2253977-80-7 | 2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253984-97-1 | S(R)]-N-[(1S)-1-[2-(Dicyclohexylphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide |
2253984-98-2 | S(R)]-N-[(1S)-1-[2-(Dicyclohexylphosphino)phenyl]-2,2-dimethylpropyl]-N,2-dimethyl-2-propanesulfinamide |
2253984-99-3 | INDEX NAME NOT YET ASSIGNED |
2254001-81-3 | ZK824859 |
2254004-96-9 | Pyridine, 5-[5-(3,4-difluorophenyl)-1,2,4-oxadiazol-3-yl]-2-methyl- |
2254029-91-7 | Alsevalimab |
2254061-60-2 | Divozilimab |
2254096-95-0 | 4H,?6H-?Benzo[1,?2-?b:5,?4-?b']?dipyran-?4-?one, 7-?[(6-?O-?D-?apio-?β-?D-?furanosyl-?β-?D-?glucopyranosyl)?oxy]?-?7,?8-?dihydro-?5-?hydroxy-?2,?8,?8-?trimethyl-?, (7S)?- |
2254096-97-2 | 5H-Furo[3,2-g][1]benzopyran-5-one, 2-[1-[(6-O-D-apio-β-D-furanosyl-β-D-glucopyranosyl)oxy]-1-methylethyl]-2,3-dihydro-4-hydroxy-7-methyl-, (2S)- |
2254096-98-3 | 5H-Furo[3,2-g][1]benzopyran-5-one, 2-[1-(β-D-glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-4-hydroxy-7-methyl-, (2S)- |
2254100-49-5 | Osimertinib-13CD3 |
2254105-61-6 | Deferasirox Impurity 6 |
2254118-43-7 | Upifitamab |
2254147-00-5 | 1H-Indazole, 5-bromo-6-(trifluoromethyl)- |
2254147-03-8 | 7-fluoro-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole |
2254168-91-5 | 1H-Indole, 4-bromo-7-chloro-5-fluoro- |
2254176-11-7 | (S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride |
2254230-02-7 | [1,1'-Biphenyl]-4-carbonitrile, 4'-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthalenyl]- |
2254325-49-8 | (2S,3S)-6-Mesityl-2,3-diphenyl-2,3-dihydroimidazo[1,2-c]quinazolin-6-ium tetrafluoroborate |
2254393-29-6 | VNL5 (Des-(((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)carbamoyl) Venetoclax Impurity) |
2254409-25-9 | ALK2-IN-2 |
2254411-77-1 | [1,1'-Biphenyl]-4-carboxylic acid, 4'-[3,7-bis(4-carboxyphenyl)-10H-phenothiazin-10-yl]- |